financetom
Business
financetom
/
Business
/
Fortune Brands Innovations Fiscal Q3 Adjusted Earnings, Net Sales Fall; 2025 Adjusted EPS Outlook Lowered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fortune Brands Innovations Fiscal Q3 Adjusted Earnings, Net Sales Fall; 2025 Adjusted EPS Outlook Lowered
Oct 31, 2025 1:17 AM

03:53 AM EDT, 10/31/2025 (MT Newswires) -- Fortune Brands Innovations ( FBIN ) reported fiscal Q3 adjusted earnings late Thursday of $1.09 per diluted, down from $1.16 a year earlier.

Analysts polled by FactSet expected $1.11.

Net sales for the quarter ended Sept. 27 were $1.15 billion, compared with $1.16 billion a year earlier.

Analysts surveyed by FactSet expected $1.18 billion.

For 2025, the company said it now expects adjusted EPS in the range of $3.70 to $3.80, compared with its prior range of $3.75 to $3.95. Analysts polled by FactSet expect $3.78.

Shares of the company were up 3.5% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Mar 15, 2024
01:33 PM EDT, 03/15/2024 (MT Newswires) -- Consumer stocks were lower Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) decreasing 0.1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) shedding 1%. In corporate news, McDonald's (MCD) temporarily closed some restaurants Friday following a tech outage that impacted its app and hindered customers' ability to place orders...
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
Mar 15, 2024
March 15 (Reuters) - Eli Lilly's ( LLY ) powerful weight-loss drug Zepbound hit 77,590 new prescriptions in the U.S. for the week ending March 8, surpassing Novo Nordisk's rival obesity medicine Wegovy for the first time since it was launched, according to data from IQVIA ( IQV ). Some 6,000 fewer Wegovy prescriptions were filled in the United States...
National Bank on Open Text Investor Meeting
National Bank on Open Text Investor Meeting
Mar 15, 2024
01:35 PM EDT, 03/15/2024 (MT Newswires) -- National Bank met investors with Open Text ( OTEX ) CEO / CTO Mark Barrenechea today. Analyst Richard Tse learned Open Text's ( OTEX ) pending divestiture of AMC is on track to close by June 2024. The pending delevering event will put OpenText back onto more acquisitions. Open Text ( OTEX )...
CoStar Group Shares Rise After Reporting Increase in Homes.com Traffic in February
CoStar Group Shares Rise After Reporting Increase in Homes.com Traffic in February
Mar 15, 2024
01:32 PM EDT, 03/15/2024 (MT Newswires) -- CoStar Group ( CSGP ) shares rose more than 7% in recent Friday trading after the company said that Homes.com reached over 149 million unique visitors in February. Homes.com's traffic growth soared 567% year over year in February. The trend followed CoStar Group's ( CSGP ) announcement of a more than $1 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved